4,5-DIMETHYL-2-PHENYLAZO-N-RIBITYL-5'-PHOSPHATE-BIS-[2-(METHYLSUFONYL)-ETHYL]-ANILINE
Compound with spectra: 2 NMR
![4,5-DIMETHYL-2-PHENYLAZO-N-RIBITYL-5'-PHOSPHATE-BIS-[2-(METHYLSUFONYL)-ETHYL]-ANILINE](/api/compound/3MG1awNBaiT.png?ph=true&h=300&w=458 "4,5-DIMETHYL-2-PHENYLAZO-N-RIBITYL-5'-PHOSPHATE-BIS-[2-(METHYLSUFONYL)-ETHYL]-ANILINE")
| SpectraBase Compound ID | 3MG1awNBaiT |
|---|---|
| InChI | InChI=1S/2C25H38N3O11PS2/c2*1-18-14-21(22(15-19(18)2)28-27-20-8-6-5-7-9-20)26-16-23(29)25(31)24(30)17-39-40(32,37-10-12-41(3,33)34)38-11-13-42(4,35)36/h2*5-9,14-15,23-26,29-31H,10-13,16-17H2,1-4H3/b2*28-27+ |
| InChIKey | LXCMHUKDLUIHAD-BZPFFPCBSA-N |
| Mol Weight | 1303.4 g/mol |
| Molecular Formula | C50H76N6O22P2S4 |
| Exact Mass | 1302.337077 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO |
2-(p-METHOXYPHENYL)-2,3,4,5-TETRAHYDRO-3,7,8-TRIMETHYL-1H-1,5-BENZODIAZEPINE
N-{4-[(E)-phenyldiazenyl]-3-[(tetrahydro-2-furanylcarbonyl)amino]phenyl}tetrahydro-2-furancarboxamide
2,3-dihydro-7,8-dimethyl-4-(p-ethoxyphenyl)-1H-1,5-benzodiazepine
4-Cyclopropyl-2,3-dihydro-7,8-dimethyl-1H-1,5-benzodiazepin-2-one
1,5-dimethyl-N-{5-methyl-2-[(E)-(2-methylphenyl)diazenyl]phenyl}-1H-pyrazole-3-carboxamide
N-(2-Cyanoethyl)-N-(2-acetoxyethyl)-3-acetylamino-4-(2-chloro-4-nitrophenylazo)-aniline
3,5-BIS-[3-DODECYLOXY-5-[2-[2-[2-[2-[METHYL-[4-(4-NITROPHENYLAZO)-PHENYL]-AMINO]-ETHOXY]-ETHOXY]-ETHOXY]-ETHOXY]-BENZYLOXY]-PHENYL]-METHANOL
2-(4-Ethoxy-2-nitro-anilino)tetrahydropyran-3,4,5-triol
1-Deoxy-1-(3,4-dimethyl-anilino)-2,3:4,5-bis(O-isopropylidene)-ribitose
6-O-(2-AMINOETHYL)PHOSPHONO-2-ACETAMIDO-2-DEOXY-ALPHA-D-GLUCOPYRANOSE
| Title | Journal or Book | Year |
|---|---|---|
| A Convenient Method to Prepare Labile FMN Derivatives | Molecules | 2001 |